Aveanna Healthcare 2025 Q3 Earnings Strong Turnaround with 132.8% Net Income Surge

Aveanna Healthcare (AVAH) reported third-quarter 2025 earnings, . The company raised full-year revenue and EBITDA guidance, reflecting improved operational performance and strategic execution.

Revenue

, driven by robust growth across key segments. , fueled by higher patient hours and improved rates. Home Health & , . The PDS segment’s strong performance, coupled with improved margins, underscored the company’s ability to capitalize on demand for home-based care.

Earnings/Net Income

Aveanna returned to profitability, , . , . , reflecting disciplined cost management and operational efficiency. The company’s earnings turnaround from a $0.22 loss to $0.07 per share underscores its operational improvements and strategic initiatives.

Post-Earnings Price Action Review

Following the earnings release, Aveanna’s stock price experienced mixed short-term performance. , , . . Despite the earnings beat, market reaction remained tempered, potentially reflecting concerns over long-term growth sustainability and broader sector dynamics.

CEO Commentary

. He attributed the results to improved rates, volume, and cost savings, as well as the integration of Thrive Skilled Pediatrics. Shaner reiterated confidence in the company’s , regulatory advocacy, and operational execution, while acknowledging labor market challenges and Medicaid rate uncertainties.

Guidance

, the 53rd-week benefit, and strategic progress. The CEO emphasized cautious optimism amid regulatory risks but expressed confidence in leveraging scale and partnerships to sustain growth.

Additional News

Recent developments include the acquisition of Thrive Skilled Pediatrics, which is on track for integration by year-end, and the expansion of preferred payer agreements, adding five new agreements in Q3. Additionally, Aveanna completed a debt refinancing, extending term loan maturities to 2030 and 2032, .